Submit Deal

CONCENTRA BIOSCIENCES

HQ - Cambridge, MA

Summary

Concentra Biosciences is an unfunded company based in Canada, founded in 2023. It operates as a Provider of clinical & business development services.

Deals Overview

Total Deals6

Valued Deals5

Total Value£ 276 M

Avg. Deal Size£ 55 M

Market Context

Senior Management

Kevin Tang
CEO
Keith Newton
President and CEO
Matt DiCanio
President and CFO

Sort

22 Dec 2023|United States|Biotechnology

Target: THESEUS PHARMACEUTICALS

Bidder: CONCENTRA BIOSCIENCES

4 Service Providers

3 Target | 1 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 148 M

Value

02 Apr 2025|United States|Biotechnology

Target: ALLAKOS INC

Bidder: CONCENTRA BIOSCIENCES

5 Service Providers

3 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 22 M

Value

01 May 2025|United States|Pharmaceuticals

Target: KRONOS BIO

Bidder: CONCENTRA BIOSCIENCES

6 Service Providers

4 Target | 2 Bidder

17 Dealmakers

14 Target | 3 Bidder

£ 26 M

Value

09 Jun 2025|United States|Biotechnology

Target: ELEVATION ONCOLOGY

Bidder: CONCENTRA BIOSCIENCES

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

2 Target | 3 Bidder

£ 19 M

Value

01 Jul 2025|United States|Biotechnology

Target: IGM BIOSCIENCES

Bidder: CONCENTRA BIOSCIENCES

5 Service Providers

3 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 59 M

Value

08 Jul 2025|United States|Biotechnology

Target: CARGO THERAPEUTICS

Bidder: CONCENTRA BIOSCIENCES

6 Service Providers

4 Target | 2 Bidder

3 Dealmakers

2 Target | 1 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy